Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study

scientific article

Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NEUROSCIENCE.2004.08.010
P698PubMed publication ID15501598
P5875ResearchGate publication ID8214748

P2093author name stringZhang J
Rahman S
Corrigall WA
Engleman EA
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectdopamineQ170304
nicotineQ12144
P304page(s)415-424
P577publication date2004-01-01
P1433published inNeuroscienceQ15708571
P1476titleNeuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study
P478volume129

Reverse relations

cites work (P2860)
Q37081416A psychobiological framework of the substrates that mediate nicotine use during adolescence
Q47225379Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine
Q26996271Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction
Q36797967Animal models and treatments for addiction and depression co-morbidity
Q48649471Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice
Q48139910Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking behaviour in response to drug-associated stimuli in rats
Q42516910Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.
Q33616676Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose.
Q45983401Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.
Q48591704Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction
Q46706771Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes
Q37821386Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse
Q42682263Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine
Q33786352Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats
Q46882400Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study
Q35892693Ethanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shell
Q42860453Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity
Q34359105Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addiction
Q37163861Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal
Q36703862Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug
Q28513200Long-term effects of chronic nicotine exposure on brain nicotinic receptors
Q27687645Mechanistic insights into nicotine withdrawal
Q43117098Microdialysis in the rat striatum: effects of 24 h dexamethasone retrodialysis on evoked dopamine release and penetration injury
Q37508580Modeling nicotinic neuromodulation from global functional and network levels to nAChR based mechanisms
Q91991315Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Q28111991New mechanisms and perspectives in nicotine withdrawal
Q28111990Nicotine and endogenous opioids: Neurochemical and pharmacological evidence
Q37525085Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction
Q37760463Nicotine: alcohol reward interactions
Q35142884Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus
Q34359231Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system
Q42488958Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration
Q30494110Progressive and lasting amplification of accumbal nicotine-seeking neural signals
Q42171451Regional brain activity correlates of nicotine dependence
Q34173418Reward, addiction, withdrawal to nicotine
Q35779214Shifting pharmacology of nicotine use and withdrawal: breaking the cycle of drug abuse
Q38345709Smoking abstinence and neurocognition: implications for cessation and relapse
Q34164290Spectral confocal imaging of fluorescently tagged nicotinic receptors in knock-in mice with chronic nicotine administration
Q42709614The effects of nicotine and tobacco particulate matter on dopamine uptake in the rat brain
Q35171303The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats
Q36933882The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Q41405373Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal
Q36798993Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study.
Q43289473Voluntary nicotine consumption triggers in vivo potentiation of cortical excitatory drives to midbrain dopaminergic neurons.
Q35583364Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens
Q36054871α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo
Q35264378α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease

Search more.